Trial intelligence / Profile preview

Early phase 2 study of NST-141 ointment in atopic dermatitis

jRCT2080221375Phase 2

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Feb 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing NST-141 1% ointment with Placebo ointment (2 arms).

02

Drugs

NST-141
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on jRCT2080221375.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221375.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call